Real-time Estimate
Cboe BZX
10:05:52 2024-05-10 am EDT
|
5-day change
|
1st Jan Change
|
8.045
USD
|
-2.96%
|
|
-19.70%
|
-21.01%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
653
|
518.8
|
415.8
|
-
|
-
|
Enterprise Value (EV)
1 |
1,213
|
1,044
|
920.9
|
896.7
|
906.8
|
P/E ratio
|
10.4
x
|
-6.43
x
|
39.1
x
|
29.2
x
|
36
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.6
x
|
0.5
x
|
0.38
x
|
0.37
x
|
0.34
x
|
EV / Revenue
|
1.12
x
|
1
x
|
0.85
x
|
0.79
x
|
0.75
x
|
EV / EBITDA
|
7.62
x
|
10.7
x
|
9.05
x
|
8.34
x
|
7.86
x
|
EV / FCF
|
16.6
x
|
23.3
x
|
23.6
x
|
19.6
x
|
-
|
FCF Yield
|
6.02%
|
4.3%
|
4.23%
|
5.1%
|
-
|
Price to Book
|
0.77
x
|
0.77
x
|
0.61
x
|
0.59
x
|
0.57
x
|
Nbr of stocks (in thousands)
|
49,618
|
50,130
|
50,156
|
-
|
-
|
Reference price
2 |
13.16
|
10.35
|
8.290
|
8.290
|
8.290
|
Announcement Date
|
2/15/23
|
3/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,083
|
1,046
|
1,082
|
1,132
|
1,208
|
EBITDA
1 |
-
|
159.3
|
97.6
|
101.8
|
107.5
|
115.4
|
EBIT
1 |
-
|
107.6
|
66.7
|
67.82
|
71.42
|
82.32
|
Operating Margin
|
-
|
9.93%
|
6.37%
|
6.27%
|
6.31%
|
6.82%
|
Earnings before Tax (EBT)
1 |
-
|
93.5
|
-90.4
|
17.51
|
24.13
|
26.86
|
Net income
1 |
111.1
|
62.5
|
-80.5
|
10.59
|
14.53
|
11.69
|
Net margin
|
-
|
5.77%
|
-7.69%
|
0.98%
|
1.28%
|
0.97%
|
EPS
2 |
-
|
1.260
|
-1.610
|
0.2120
|
0.2840
|
0.2300
|
Free Cash Flow
1 |
-
|
73
|
44.9
|
38.95
|
45.72
|
-
|
FCF margin
|
-
|
6.74%
|
4.29%
|
3.6%
|
4.04%
|
-
|
FCF Conversion (EBITDA)
|
-
|
45.83%
|
46%
|
38.26%
|
42.53%
|
-
|
FCF Conversion (Net income)
|
-
|
116.8%
|
-
|
367.74%
|
314.72%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/4/22
|
2/15/23
|
3/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
268
|
265.7
|
275.1
|
265.1
|
262.3
|
258.3
|
260.6
|
262.4
|
268.6
|
272.6
|
275.4
|
281.3
|
EBITDA
1 |
40.3
|
31.7
|
40.3
|
25.3
|
23.9
|
23.2
|
25.2
|
25.3
|
24.55
|
25.59
|
27.26
|
25.64
|
EBIT
1 |
32.1
|
23.7
|
27
|
14.2
|
16.2
|
15.5
|
17.5
|
12.9
|
16.48
|
16.79
|
18.86
|
17.5
|
Operating Margin
|
11.98%
|
8.92%
|
9.81%
|
5.36%
|
6.18%
|
6%
|
6.72%
|
4.92%
|
6.14%
|
6.16%
|
6.85%
|
6.22%
|
Earnings before Tax (EBT)
1 |
-
|
11.7
|
19.2
|
4.2
|
-84.7
|
-3
|
-7.4
|
1.1
|
3.131
|
3.112
|
5.881
|
4.121
|
Net income
1 |
20.34
|
8.6
|
7.7
|
2.7
|
-74.4
|
-2.4
|
-6.4
|
2.46
|
1.923
|
2.623
|
4.3
|
3.05
|
Net margin
|
7.59%
|
3.24%
|
2.8%
|
1.02%
|
-28.36%
|
-0.93%
|
-2.46%
|
0.92%
|
0.72%
|
0.96%
|
1.56%
|
1.08%
|
EPS
2 |
0.4100
|
0.1700
|
0.1500
|
0.0500
|
-1.490
|
-0.0500
|
-0.1300
|
0.0100
|
0.0300
|
0.0660
|
0.0850
|
0.0600
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/1/22
|
11/1/22
|
2/15/23
|
5/9/23
|
8/9/23
|
11/7/23
|
3/6/24
|
5/8/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
560
|
525
|
505
|
481
|
491
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
3.517
x
|
5.381
x
|
4.962
x
|
4.474
x
|
4.254
x
|
Free Cash Flow
1 |
-
|
73
|
44.9
|
38.9
|
45.7
|
-
|
ROE (net income / shareholders' equity)
|
-
|
6.55%
|
1.59%
|
1.8%
|
2.66%
|
2.93%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
17.00
|
13.40
|
13.70
|
14.10
|
14.50
|
Cash Flow per Share
2 |
-
|
1.610
|
0.9700
|
1.000
|
1.150
|
-
|
Capex
1 |
-
|
7.1
|
3.5
|
7.33
|
7.25
|
8.23
|
Capex / Sales
|
-
|
0.66%
|
0.33%
|
0.68%
|
0.64%
|
0.68%
|
Announcement Date
|
4/4/22
|
2/15/23
|
3/6/24
|
-
|
-
|
-
|
Last Close Price
8.29
USD Average target price
10.18
USD Spread / Average Target +22.78% Consensus |
1st Jan change
|
Capi.
|
---|
| -21.01% | 416M | | -0.31% | 3.09B | | 0.00% | 1.97B | | +14.13% | 1.72B | | +58.98% | 668M | | -24.44% | 159M | | -12.04% | 139M | | +1.92% | 67.82M |
Home Healthcare Services
|